Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer

(2012) Jalees Rehman et al.   FASEB JOURNAL

Mitochondrial fusion: A mechanism of cisplatin-induced resistance in neuroblastoma cells?

(2012) Giada Santin et al.   NEUROTOXICOLOGY

Integrin adhesions

(2012) Christine Lawson et al.   Cell Adhesion & Migration

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP

(2011) Yuan Yuan et al.   Journal of Hematology & Oncology

Impairing the Mitochondrial Fission and Fusion Balance: A New Mechanism of Neurodegeneration

(2010) Andrew B. Knott et al.   Annals of the New York Academy of Sciences

Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease

(2010) A. C. Mackinnon et al.   JOURNAL OF CLINICAL PATHOLOGY

SLP-2 is required for stress-induced mitochondrial hyperfusion

(2009) Daniel Tondera et al.   EMBO JOURNAL

Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion

(2008) R. Jagadeeswaran et al.   CANCER RESEARCH

Paxillin comes of age

(2008) N. O. Deakin et al.   JOURNAL OF CELL SCIENCE

Tumor Cell Metabolism Imaging

(2008) C. Plathow et al.   JOURNAL OF NUCLEAR MEDICINE

Mitochondrial dynamics and cancer

(2008) Stéphanie Grandemange et al.   SEMINARS IN CANCER BIOLOGY